Competitive Technologies, Inc. on Independent Research

Published: Jun 04, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FAIRFIELD, Conn., June 4, 2013 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) markets and sells the CalmareĀ® medical device for the treatment of neuropathic pain. CTTC encourages investigators to conduct independent clinical trials involving the Calmare device to add to the growing body of research supporting the efficacy of Calmare in treating chronic neuropathic pain.

Help employers find you! Check out all the jobs and post your resume.

Back to news